Clinical trials
Withdrawn Phase 1 Melanoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2010 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 2 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 2 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 25 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Duke University | 2 |
| National Cancer Institute (NCI) | 2 |
| Bristol-Myers Squibb | 1 |
| Case Comprehensive Cancer Center | 1 |
| City of Hope Medical Center | 1 |
| Darell Bigner | 1 |
| GlaxoSmithKline | 1 |
| Hoffmann-La Roche | 1 |
| James Isaacs, MD | 1 |
| M.D. Anderson Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Melanoma | 25 |
| Neoplasm Metastasis | 4 |
| Sarcoma | 3 |
| Carcinoma, Renal Cell | 2 |
| Brain Neoplasms | 1 |
| Breast Neoplasms | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Colorectal Neoplasms | 1 |
| Head and Neck Neoplasms | 1 |
| Kidney Neoplasms | 1 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.